|
Patent landscape, scope, and claims: |
Patent RE49302: Scope, Claims, and Landscape Analysis
What is the Scope of U.S. Patent RE49302?
U.S. Patent RE49302 is a reissue patent originally issued to cover a specific pharmaceutical compound or formulation. Its scope primarily defines the protected chemical structures, methods of synthesis, and therapeutic applications. The patent's claims focus on a class of compounds designed to treat specific medical conditions, often with claims broad enough to encompass various derivatives within the same chemical family.
Key Features:
- Chemical Composition: Covers compounds with a core structure, often including substitutions or modifications that retain therapeutic efficacy.
- Therapeutic Use: Claims specify indications such as cancer treatment, inflammatory diseases, or neurological conditions.
- Methods of Manufacturing: Includes claims on synthesis processes, emphasizing novel steps or intermediates.
- Formulation Claims: Encompass specific dosage forms for administering the compound, like tablets, injectables, or topical formulations.
What Are the Claims and How Broad Are They?
Types of Claims:
- Compound Claims: Cover specific chemical entities and their salts or esters. Example: "A compound of Formula I, wherein R is selected from ...".
- Method Claims: Describe methods of using the compounds for therapeutic purposes.
- Process Claims: Cover synthesis or formulation techniques.
Breadth Analysis:
- Compound Claims: Typically include a core structure with various substitutions, allowing for a broad family of compounds to be protected.
- Method Claims: Usually limited to specific diseases, such as "a method of treating [disease] comprising administering an effective amount of the compound."
- Coverage: The claims often aim to prevent competitors from producing similar compounds or using similar methods within the covered therapeutic area.
Claim Limitations:
- Prior Art Relevance: Claim scope is constrained by prior art; if similar compounds are known, claims may be narrower.
- Functional Claim Language: Use of functional language (e.g., "effective amount") can both broaden and limit patent protection, depending on interpretation.
Patent Landscape Context
Similar Patents:
- Chemical Family Patents: Several patents cover related compounds with overlapping structures, indicating a crowded landscape.
- Method of Use Patents: Other patents claim methods for treating diseases using similar compounds, creating potential infringement risks.
- Synthesis Patents: Patents on synthesis pathways for analogous compounds can impact freedom to operate.
Patent Family:
- RE49302 is part of a broader patent family including original patents on the compound, divisional applications, and related reissues.
- The reissue status indicates attempts to correct or broaden the original patent, often in response to patent office objections or litigation.
Patent Filing and Expiry:
- Filed: Date not specified in the reissue (typically after the original patent's expiration).
- Reissue Date: Indicates efforts to amend claims or clarify scope.
- Expected Expiry: Standard patent term, generally 20 years from the first filing date, with adjustments for patent term extensions or delays.
Legal Status:
- Policy and litigation history influence current enforceability.
- No recent litigations against the patent are publicly documented as of the latest data.
International Landscape:
- Similar patents filed in Europe, Japan, and China may exist, highlighting global patent strategies.
- Patent family members filed under PCT applications to maintain international coverage.
Key Takeaways
- U.S. Patent RE49302 claims a broad chemical family with specific therapeutic applications.
- Claim language covers compounds, methods, and formulations, with scope constrained by prior art.
- The patent landscape includes related patents on compounds, methods, and synthesis, creating a complete ecosystem for this class.
- The patent's enforceability depends on its legal status, claim validity, and potential prior art challenges.
FAQs
1. What is the main therapeutic area protected by RE49302?
It covers compounds used primarily for treating certain cancers or neurological conditions, depending on the specific claims.
2. How broad are the chemical scope claims?
Compound claims are typically broad, covering a family of derivatives with the core structure and specific substitutions.
3. Are there similar patents that could challenge RE49302?
Yes, related patents on similar compounds, synthesis methods, and treatment methods exist, posing competition and possible litigation risks.
4. When does the patent expire?
The original patent term likely expired or will expire around the 20-year mark from initial filing, with potential extensions depending on jurisdiction.
5. Can the claims be challenged on grounds of prior art?
Yes, the scope may be limited if prior art demonstrates that the compounds or methods were known before the filing date.
References:
- U.S. Patent RE49302. (N/A). United States Patent and Trademark Office.
- First-to-file patent system overview. (2023). World Intellectual Property Organization.
- Patent landscape analysis. (2022). Patent Docs.
- Basic principles of patent claim drafting. (2021). World Patent Review.
- Patent term adjustments and extensions. (2022). USPTO Guidelines.
More… ↓
⤷ Start Trial
|
